Cite

HARVARD Citation

    Short, N. et al. (2018). A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B‐cell acute lymphoblastic leukaemia. British journal of haematology. pp. 442-444. [Online]. 
  
Back to record